| Irinotecan-Eluting Beads in Treating Patients With Refractory Metastatic Colon or Rectal Cancer That Has Spread to the Liver (NCT02110953) | Fox Chase Cancer Center | 2016-01-29 |
| Ziv-Aflibercept Followed by Ziv-Aflibercept, Fluorouracil, and Leucovorin Calcium in Treating Patients With Stage IV Colorectal Cancer (NCT02235324) | University of Southern California | 2015-03-01 |
| CPI-613 and Fluorouracil in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by Surgery (NCT02232152) | Wake Forest University Health Sciences | 2015-01-06 |
| MEK Inhibitor MEK162 in Combination With Leucovorin Calcium, Fluorouracil, and Oxaliplatin in Treating Patients With Advanced Metastatic Colorectal Cancer (NCT02041481) | City of Hope Medical Center | 2014-06-01 |
| Short-Infusion Ziv-aflibercept in Treating Patients With Metastatic Colorectal Cancer Receiving Combination Chemotherapy (NCT01941173) | City of Hope Medical Center | 2014-01-01 |
| Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers (NCT01846520) | City of Hope Medical Center | 2013-10-01 |
| Irinotecan and Alisertib in Treating Patients With Advanced Solid Tumors or Colorectal Cancer (NCT01923337) | University of California, Davis | 2013-08-01 |
| PET-MRI in Diagnosing Patients With Colon or Rectal Cancer (NCT01807117) | Case Comprehensive Cancer Center | 2013-04-01 |
| 18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy (NCT01806675) | Sanjiv Sam Gambhir | 2013-03-04 |
| Panitumumab and Chemotherapy in Patients With Advanced Colorectal Cancer After Prior Therapy With Bevacizumab (NCT01814501) | John Hays | 2013-02-01 |
| Ipilimumab and Local Radiation for Selected Solid Tumors (NCT01769222) | Stanford University | 2013-02-01 |
| Selumetinib and Cetuximab in Treating Patients With Refractory Solid Tumors (NCT01217450) | National Cancer Institute (NCI) | 2012-10-01 |
| Vaccine Therapy in Treating Patients With Colorectal, Stomach, or Pancreatic Cancer (NCT01191684) | City of Hope Medical Center | 2011-10-01 |
| Linifanib in Treating Patients With Advanced, Refractory Colorectal Cancer (NCT01365910) | Vanderbilt-Ingram Cancer Center | 2011-06-01 |
| Supportive Intervention Programs Study (NCT01590147) | Wake Forest University | 2011-06-01 |
| Radiolabeled Monoclonal Antibody Therapy, Combination Chemotherapy, and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer (NCT01205022) | City of Hope Medical Center | 2011-04-01 |
| Combination Chemotherapy and Bevacizumab Before Surgery and Radiolabeled Monoclonal Antibody Therapy in Treating Liver Metastases in Patients With Metastatic Colorectal Cancer (NCT01320683) | City of Hope Medical Center | 2011-03-01 |
| Study of AUY922 and Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal Cancer (NCT01294826) | Swedish Medical Center | 2011-02-01 |
| Combination Chemotherapy and Bevacizumab With or Without RO4929097 in Treating Patients With Metastatic Colorectal Cancer (NCT01270438) | National Cancer Institute (NCI) | 2010-12-01 |
| Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors (NCT01233505) | National Cancer Institute (NCI) | 2010-10-01 |
| Chemoembolization Using Irinotecan in Treating Patients With Liver Metastases From Metastatic Colon or Rectal Cancer (NCT01285102) | Fox Chase Cancer Center | 2010-10-01 |
| Panobinostat and Fluorouracil Followed By Leucovorin Calcium in Treating Patients With Stage IV Colorectal Cancer Who Did Not Respond to Previous Fluorouracil-Based Chemotherapy (NCT01238965) | University of Southern California | 2010-10-01 |
| RO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors (NCT01158274) | National Cancer Institute (NCI) | 2010-06-01 |
| RO4929097 in Treating Patients With Metastatic Colorectal Cancer (NCT01116687) | National Cancer Institute (NCI) | 2010-05-01 |
| Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC) (NCT01126346) | Wake Forest University Health Sciences | 2010-05-01 |
| Azacitidine and Entinostat in Treating Patients With Metastatic Colorectal Cancer (NCT01105377) | National Cancer Institute (NCI) | 2010-04-01 |
| Cetuximab and/or Dasatinib in Patients With Colorectal Cancer and Liver Metastases That Can Be Removed by Surgery (NCT00835679) | National Cancer Institute (NCI) | 2009-12-01 |
| Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer (NCT01037790) | Abramson Cancer Center at Penn Medicine | 2009-10-01 |
| Sorafenib and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer (NCT00826540) | Alliance for Clinical Trials in Oncology | 2009-09-01 |
| Vorinostat, Fluorouracil, and Leucovorin Calcium in Treating Patients With Metastatic Colorectal Cancer That Has Not Responded to Previous Treatment (NCT00942266) | Roswell Park Cancer Institute | 2009-07-01 |
| Cetuximab and Everolimus in Treating Patients With Metastatic or Recurrent Colon Cancer or Head and Neck Cancer (NCT01637194) | Fox Chase Cancer Center | 2008-11-01 |
| Erlotinib Hydrochloride in Treating Patients With Stage I-III Colorectal Cancer or Adenoma (NCT00754494) | National Cancer Institute (NCI) | 2008-07-01 |
| Pertuzumab and Cetuximab in Treating Patients With Previously Treated Locally Advanced or Metastatic Colorectal Cancer (NCT00551421) | National Cancer Institute (NCI) | 2007-10-01 |
| Dasatinib in Treating Patients With Previously Treated Metastatic Colorectal Cancer (NCT00504153) | National Cancer Institute (NCI) | 2007-07-01 |
| Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy (NCT00499369) | National Cancer Institute (NCI) | 2007-06-01 |
| Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer (NCT00397384) | National Cancer Institute (NCI) | 2007-01-01 |
| AZD0530 (NSC 735464) in Treating Patients With Previously Treated Metastatic Colon Cancer or Rectal Cancer (NCT00397878) | National Cancer Institute (NCI) | 2006-11-01 |
| VEGF Trap in Treating Patients With Previously Treated Metastatic Colorectal Cancer (NCT00407654) | National Cancer Institute (NCI) | 2006-10-01 |
| Suberoylanilide Hydroxamic Acid, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Progressive Metastatic or Unresectable Colorectal Cancer or Other Solid Tumors (NCT00138177) | National Cancer Institute (NCI) | 2005-07-01 |
| Sorafenib, Cetuximab, and Irinotecan in Treating Patients With Advanced or Metastatic Colorectal Cancer (NCT00134069) | National Cancer Institute (NCI) | 2005-06-01 |
| Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas (NCT00101270) | National Cancer Institute (NCI) | 2005-03-01 |
| Hepatic Arterial Infusion of Floxuridine, Gemcitabine Hydrochloride, and Radiolabeled Monoclonal Antibody Therapy in Treating Liver Metastases in Patients With Metastatic Colorectal Cancer Previously Treated With Surgery (NCT00645710) | City of Hope Medical Center | 2005-02-11 |
| Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer (NCT00101348) | National Cancer Institute (NCI) | 2005-01-01 |
| SB-715992 in Treating Patients With Advanced or Metastatic Colorectal Cancer (NCT00103311) | National Cancer Institute (NCI) | 2005-01-01 |
| Phase II Trial of FOLFOX6, Bevacizumab and Cetuximab in Patients With Colorectal Cancer (NCT00100841) | National Cancer Institute (NCI) | 2004-11-01 |
| Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment (NCT00091182) | National Cancer Institute (NCI) | 2004-10-01 |
| GTI-2040, Oxaliplatin, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer or Other Solid Tumors (NCT00084643) | National Cancer Institute (NCI) | 2004-05-01 |
| EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer (NCT00087191) | National Cancer Institute (NCI) | 2004-05-01 |
| Combination Chemotherapy and Bevacizumab in Treating Patients With Locally Advanced, Metastatic, or Recurrent Colorectal Cancer (NCT00070122) | National Cancer Institute (NCI) | 2004-04-01 |
| 2 Phase Comparison of Pre-operative CT and PET Images for Metastatic Colorectal Cancer (NCT01821105) | Ohio State University Comprehensive Cancer Center | 2004-03-01 |
| Bevacizumab and Cetuximab With or Without Irinotecan in Treating Patients With Irinotecan-Refractory Metastatic Colorectal Cancer (NCT00077298) | National Cancer Institute (NCI) | 2003-12-01 |
| A Phase I, Pharmacological, and Biological Study of OSI-774 in Combination With FOLFOX 4 (5-FU, Leucovorin, and Oxaliplatin) and Bevacizumab (Avastin) in Patients With Advanced Colorectal Cancer (NCT00060411) | National Cancer Institute (NCI) | 2003-06-01 |
| Gefitinib and Combination Chemotherapy in Treating Patients With Advanced or Recurrent Colorectal Cancer (NCT00052585) | National Cancer Institute (NCI) | 2002-10-01 |
| Imatinib Mesylate in Treating Patients With Stage IV Colorectal Cancer (NCT00041340) | National Cancer Institute (NCI) | 2002-05-01 |
| Hepatic Arterial Infusion Plus Chemotherapy in Treating Patients With Colorectal Cancer Metastatic to the Liver (NCT00026234) | National Cancer Institute (NCI) | 2002-02-01 |
| Erlotinib in Treating Patients With Recurrent or Metastatic Colorectal Cancer (NCT00032110) | National Cancer Institute (NCI) | 2002-01-01 |
| 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) (NCT00031681) | National Cancer Institute (NCI) | 2001-12-01 |
| Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction (NCT00030498) | National Cancer Institute (NCI) | 2001-12-01 |
| Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer (NCT00028496) | National Cancer Institute (NCI) | 2001-11-01 |
| Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Recurrent or Persistent Metastatic Colorectal Cancer (NCT00023933) | National Cancer Institute (NCI) | 2001-10-01 |
| Combination Chemotherapy With or Without Bevacizumab Compared With Bevacizumab Alone in Treating Patients With Advanced or Metastatic Colorectal Cancer That Has Been Previously Treated (NCT00025337) | National Cancer Institute (NCI) | 2001-09-01 |
| SU5416 and Irinotecan in Treating Patients With Advanced Colorectal Cancer (NCT00005818) | National Cancer Institute (NCI) | 2000-03-01 |
| Irinotecan Compared With Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer (NCT00005036) | National Cancer Institute (NCI) | 1999-11-01 |
| Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu (NCT00004074) | National Cancer Institute (NCI) | 1999-08-01 |
| Fluorouracil With or Without Eniluracil in Treating Patients With Advanced Colorectal Cancer (NCT00003873) | National Cancer Institute (NCI) | 1999-04-01 |
| Isolated Hepatic Perfusion With Melphalan Followed By Chemotherapy in Treating Patients With Unresectable Colorectal Cancer That is Metastatic to the Liver (NCT00019760) | National Institutes of Health Clinical Center (CC) | 1999-04-01 |
| Phase I-II Study of Fluorouracil in Combination With Phenylbutyrate in Advanced Colorectal Cancer (NCT00002796) | National Cancer Institute (NCI) | 1997-05-01 |
| Vaccine Therapy in Treating Patients With Colon, Pancreatic, or Lung Cancer (NCT00019006) | National Cancer Institute (NCI) | 1995-03-01 |
| Antineoplaston Therapy in Treating Patients With Colon Cancer (NCT00003486) | Burzynski Research Institute | |